Zydus Therapeutics Reports Positive Topline Results from EPICS-III Phase 2(b)/3 Trial of Saroglitazar Magnesium in Patients with Primary Biliary Cholangitis
Bengaluru, – August 29th, 2025 – Zydus Therapeutics, a wholly owned subsidiary of Zydus Lifesciences...